Institute of Cardiovascular Sciences We are leaders in cardiovascular research, including atrial fibrillation and heart failure, thrombosis/thrombo-inflammation and vascular biology.
News New research award to investigate and treat thrombo-inflammation in diseases where red blood cell destruction occurs Dr Julie Rayes, Researcher in Cardiovascular Sciences within the Birmingham Platelet Group at the Institute of Cardiovascular Sciences (ICVS), University of Birmingham, has been awarded a highly regarded Intermediate Fellowship to better understand and to test and repurpose drugs to limit thrombo-inflammation when it is caused by infection or congenital disorders involving the destruction of red blood cells.
News Clinical trial led by Bimingham Professor shows digoxin is effective for treatment of atrial fibrillation
Posted 14 April 2021 New research award to investigate and treat thrombo-inflammation in diseases where red blood cell destruction occurs Dr Julie Rayes has been awarded a highly regarded Intermediate Fellowship to better understand and to test and repurpose drugs to limit thrombo-inflammation when it is caused by infection or congenital disorders.
Posted 31 March 2021 Machine learning and AI for early detection of atrial fibrillation and stroke A new EU-funded collaborative research project will develop the first integrative digital platform for diagnosing atrial cardiomyopathy.
Posted 24 March 2021 Experts publish key recommendations for innovation in atrial fibrillation Experts have come together to discuss the latest innovations in atrial fibrillation research and publish a set of agreed clinical and research recommendations.
Posted 15 March 2021 Karger: Spotlight on Professor Dipak Kotecha, Associate Editor Article about Professor Dipak Kotecha, Associate Editor of Karger and Professor of Cardiology at the Institute of Cardiovascular Sciences, where he talks about himself and his research.